Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
14.36
+0.08 (0.55%)
Nov 5, 2024, 1:06 PM EST - Market open
Cadrenal Therapeutics Employees
Cadrenal Therapeutics had 4 employees as of December 31, 2023. The number of employees increased by 1 or 33.33% compared to the previous year.
Employees
4
Change (1Y)
1
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,559,195
Market Cap
21.49M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | 1 | 33.33% |
Dec 31, 2022 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Retractable Technologies | 151 |
Beyond Air | 107 |
VSee Health | 40 |
MEI Pharma | 28 |
BioVie | 14 |
NeuroBo Pharmaceuticals | 8 |
Aprea Therapeutics | 7 |
ProMIS Neurosciences | 7 |
CVKD News
- 3 days ago - Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds - PRNewsWire
- 12 days ago - Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility - PRNewsWire
- 13 days ago - CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM - PRNewsWire
- 6 weeks ago - Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference - PRNewsWire
- 2 months ago - Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients - PRNewsWire
- 2 months ago - Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients - PRNewsWire
- 2 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 2 months ago - Cadrenal Therapeutics to Present at Upcoming Investor Conferences - PRNewsWire